First study to report isolation of M. saskatchewanense from medical devices

Researchers reported the first isolation of M. saskatchewanense from medical-grade equipment.

Tirzepatide treatment results in successful weight loss regardless of obesity-related complications

Having medical conditions linked to obesity does not impact the total weight loss achieved with the anti-obesity medication tirzepatide, according to an industry-supported study being

June 3, 2024

Parental cancer history associated with critical unmet needs of children

A new study by researchers at the American Cancer Society (ACS) found children of parents with a cancer history in the United States are more

June 22, 2023

Risk Adjusted Net Present Value: What is the current valuation of Roivant Sciences’s Brepocitinib tosylate

The revenue for Brepocitinib tosylate is expected to reach an annual total of $256 mn by 2035 in the US based off GlobalData’s Expiry Model.

May 16, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.